智通财经APP获悉，周五，Mobia Medical(MOBI.US)登陆美股市场，截至发稿，该股跌18%，报12.3美元。IPO价格为15美元。Mobia Medical是一家美国医疗科技公司，总部位于得州奥斯汀，主要专注于神经刺激疗法及中风康复设备研发。公司核心产品Vivistim是一款用于慢性缺血性中风康复的迷走神经刺激系统，也是目前首个获得美国FDA批准、用于帮助中风患者恢复上肢运动能力的植入式神经刺激设备。
智通财经APP获悉，周五，Mobia Medical(MOBI.US)登陆美股市场，截至发稿，该股跌18%，报12.3美元。IPO价格为15美元。Mobia Medical是一家美国医疗科技公司，总部位于得州奥斯汀，主要专注于神经刺激疗法及中风康复设备研发。公司核心产品Vivistim是一款用于慢性缺血性中风康复的迷走神经刺激系统，也是目前首个获得美国FDA批准、用于帮助中风患者恢复上肢运动能力的植入式神经刺激设备。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.